Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)

Subclass of:

514 - Drug, bio-affecting and body treating compositions

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
514183000 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI 25098
514023000 Carbohydrate (i.e., saccharide radical containing) DOAI 5294
514002000 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI 3842
514169000 Cyclopentanohydrophenanthrene ring system DOAI 1462
514553000 Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI 1460
514579000 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI 1163
514075000 Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI 1107
514506000 Ester DOAI 925
514159000 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI 297
514063000 Silicon containing DOAI 285
514724000 C-O-group (e.g., alcohol, alcoholate, etc.) DOAI 246
514675000 Ketone DOAI 192
514064000 Boron containing DOAI 184
514167000 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI 179
514152000 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI 132
514476000 N-C(=X)X containing (X is chalcogen) DOAI 119
514492000 Heavy metal containing DOAI 118
514715000 Ether DOAI 80
514150000 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide DOAI 79
514155000 Para-N-benzene - sulfoxy-N containing DOAI, and said benzene ring is not part of a polycyclo ring system 66
514693000 Aldehyde DOAI 46
514762000 Hydrocarbon DOAI 28
514706000 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) 26
514714000 Peroxide DOAI 12
514743000 Halogenated hydrocarbon DOAI 12
514740000 Nitrogen containing compound DOAI 8
514022000 Lignin or derivative DOAI 6
514065000 Pyrethrum plant derived material or plant derived rotenone compound containing DOAI 6
514149000 Azoxy DOAI 5
20090298795Thiol-Sensitive Positive Inotropes - The present invention relates to methods for treating diastolic dysfunction or a disease, disorder or condition associated with diastolic dysfunction, methods for treating heart failure, methods for modulating SR Ca2+ release and/or uptake, methods for enhancing myocyte relaxation, preload or E2P hydrolysis, and methods for treating ventricular hypertrophy.12-03-2009
20090281067Nitroxyl progenitor compounds and methods of use - Described herein are nitroxyl progenitor compounds, and compositions including, and methods or generating, the compounds thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions.11-12-2009
20090186859DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS - Disclosed are compounds that release nitric oxide, e.g., a compound of Formula (I) wherein R07-23-2009
20090203653Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors - The invention describes novel compositions comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor, and, optionally, at least one therapeutic agent. The invention also provides novel kits comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor compound, and, optionally, at least one therapeutic agent. The invention also provides methods for (a) treating cardiovascular diseases; (b) treating renovascular diseases; (c) treating diabetes; (d) treating diseases resulting from oxidative stress; (e) treating endothelial dysfunctions; (f) treating diseases caused by endothelial dysfunctions; (g) treating gastrointestinal disorders; (h) treating inflammatory disorders; and (j) treating respiratory disorders. The apocynin compound may preferably be apocynin. The nitric oxide donor compound may preferably be isosorbide dinitrate and/or isosorbide mononitrate.08-13-2009
20100298277ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure11-25-2010

Patent applications in all subclasses DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)